Oragenics, Inc

Biotechnology Research • Town & Country, Florida, United States • 11-20 Employees

Company overview

Headquarters	4902 Eisenhower Blvd, Suite 125, Tampa, FL 33634, US
Phone number	+18132867900
Website	oragenics.com
SIC	283
Keywords	Probiotcs
Employees	11-20
Socials

Key Contacts at Oragenics, Inc

Natasha Giordano

Independent Board Director

Michael Hopf

Senior Director - Worldwide Sales

Donatella Fantozzi

Director Operations Management

Oragenics, Inc Email Formats

Oragenics, Inc uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@oragenics.com), used 40% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@oragenics.com	40%
{last name}{last name}	doedoe@oragenics.com	40%
{first name}{last name}	johndoe@oragenics.com	20%

About Oragenics, Inc

Oragenics, Inc. is a development-stage company dedicated to fighting infectious diseases, including those caused by coronaviruses and multidrug-resistant organisms. Its lead product is NT-CoV2-1, an intranasal vaccine candidate to prevent COVID-19 and variants of the SARS-CoV-2 virus. The NT-CoV2-1 program leverages coronavirus spike protein research licensed from the NIH and the NRC with a focus on reducing viral transmission and offering a more patient-friendly intranasal administration. Its lantibiotics program features a novel class of antibiotics against bacteria that have developed resistance to commercial antibiotics. For more information about Oragenics, please visit www.oragenics.com.

Oragenics, Inc revenue & valuation

Annual revenue	$37,653
Revenue per employee	$2,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$120,489
Total funding	$28,540,000